Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND Application for RP7214 in SARS-CoV-2 Infection; Phase 1 Clinical Trial of RP7214 Set to Begin Early December 2020
1.12.2020 18:01:00 EET | Business Wire | Press release
Rhizen Pharmaceuticals, a clinical-stage oncology-focussed biopharmaceutical company, today announced the approval of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) to study its oral DHODH inhibitor for SARS-CoV-2 infection. The company announced that initial study shall evaluate single ascending doses of RP7214 in healthy volunteers and that dosing is expected to commence in early December 2020. The company also announces positive feedback from the FDA during its pre-IND discussion on its plans to follow-up this study with a multiple-ascending dose study in Covid-19 patients.
Dihydroorotate dehydrogenase (DHOHD) is a key enzyme involved in pyrimidine biosynthesis in the cell. RP7214 is potentially a best-in-class selective DHODH inhibitor that has shown potent inhibition of Covid-19 viral replication. RP7214 has also been studied extensively across multiple inflammation models where it has demonstrated excellent anti-inflammatory activity. Further, the IND-enabling preclinical studies have shown RP7214 to be orally available, safe and tolerable with predictable dose-linear pharmacokinetics. The host-based mechanism of RP7214 could allow complementary combinations with direct acting anti-viral drugs, while the broad anti-inflammatory action could potentially mitigate the cytokine mediated inflammatory symptoms typically seen in SARS-CoV-2 & other viral infections.
Swaroop Vakkalanka, President & CEO of Rhizen Pharmaceuticals said “There is an exceptional need for oral antiviral drugs that are suitable for Covid-19 treatment across all hospital and out-patient settings. We are pleased to advance RP7214 into a Phase 1 clinical trial for the treatment of Covid-19 under a US FDA IND. RP7214 has a unique preclinical profile, high oral bioavailability, robust anti-viral potency and broad anti-inflammatory role, that we expect will translate in the clinic and support its eventual development as a potential treatment for Covid-19”.
About Rhizen Pharmaceuticals S.A.:
Rhizen Pharmaceuticals is an innovative, clinical-stage biopharmaceutical company focused on the discovery and development of novel onco-therapeutics. Since its establishment in 2008, Rhizen has created a diverse pipeline of proprietary drug candidates targeting several cancers and immune associated cellular pathways. Rhizen is headquartered in La-Chaux-de-Fonds, Switzerland. For additional information, please visit www.rhizen.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201201005815/en/
Contact information
Samyukta Bhagwati
Manager, Corporate Affairs & Communications
Rhizen Pharmaceuticals S.A.
Telephone: +41 32 580 0113
Email: corpcomm@rhizen.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Print Infrastructure Is the Biggest Zero Trust Gap CIOs Haven’t Closed, Survey Finds7.10.2026 15:30:00 EEST | Press release
Vasion today released new research revealing a security gap hiding in plain sight across enterprise IT: CIOs and IT leaders know their print environments carry risk, but print remains largely outside their Zero Trust strategies even as failures continue to disrupt business operations. According to an independent survey of 500+ enterprise CIOs and senior IT leaders commissioned by Vasion through Censuswide, 54% of respondents describe their print environment as “actively managed, with known and accepted risks.” At the same time, 61% report that print or document workflow failures disrupt their business at least once a week. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261007677295/en/ Print Infrastructure Is the Biggest Zero Trust Gap CIOs Haven’t Closed, Survey Finds The finding points to a broader issue: print may not be viewed as broken, but it remains an accepted area of exposure and operational friction. The gap become
Oscilloquartz expands OSAinside ™ Series OSA 5400 TimeCard ™ with advanced server-integrated timing capabilities7.10.2026 15:00:00 EEST | Press release
Oscilloquartz today announced significant new capabilities for its OSAinside™ Series OSA 5400 TimeCard™, expanding the flexibility and performance of server-integrated timing for defense, data center, telecom and finance applications. With support for multiple deployment architectures and timing sources, the enhanced OSA 5400 TimeCard™ enables organizations to integrate highly accurate synchronization directly into commercial off-the-shelf (COTS) and purpose-built servers, reducing reliance on dedicated external timing appliances. Available as the OSA 5400 TimeCard™ and the OSA 5400 TAP TimeCard™, the platform supports PCIe Precision Time Measurement (PTM), multi-band L1/L5 GNSS with NavIC and Galileo OSNMA, advanced jamming and spoofing detection and multiple oscillator options for precise server-level synchronization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261007831264/en/ Oscilloquartz’s enhanced OSA 5400 TimeCard
Paraguayan Air Force Taps Cessna SkyCourier for Multi-Mission Operations7.10.2026 14:00:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced the Paraguayan Air Force (Fuerza Aérea Paraguaya) has become the first South American military operator of the Cessna SkyCourier turboprop, marking another milestone for the aircraft’s multi-mission versatility. Funded by Itaipu Binacional — a binational entity operated by the governments of Brazil and Paraguay — the aircraft joins the force’s existing fleet of Cessna Grand Caravan aircraft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261007525725/en/ The Cessna SkyCourier delivery to the Paraguayan Air Force marks the aircraft’s first South American military operation and expands the force’s multi-mission capabilities. “The Cessna SkyCourier delivers unmatched reliability and mission flexibility, enabling the Paraguayan Air Force to reach remote regions with confidence,” said Bob Gibbs, vice president, Defense & Special Mission Sales. “Its rugged
Shah Rukh Khan and Rizwan Sajan Reunite For Shahrukhz Residences by Danube With Gauri Khan-Designed Penthouses7.10.2026 13:14:00 EEST | Press release
Following success of Shahrukhz by Danube, the commercial tower that sold out on launch day, Danube Properties announces next chapter of its iconic partnership with superstar Shah Rukh Khan with the launch of Shahrukhz Residences by Danube - a landmark fully furnished waterfront residential tower in Dubai Maritime City, with apartments starting at AED 1.65 million and a flexible payment plan of 30% during construction, and 70% upon handover. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261006482573/en/ Shah Rukh Khan and Rizwan Sajan Reunite For Shahrukhz Residences by Danube With Gauri Khan-Designed Penthouses (Photo: AETOSWire) Positioned as world’s first celebrity-named residential tower, Shahrukhz Residences by Danube sets a new benchmark for celebrity-inspired living, offering breathtaking views of the sea and the Dubai skyline. Adding to its exclusivity, celebrated interior designer and SRK’s wife, Gauri Khan, has des
LTM Expands Collaboration with Google Cloud to Help Accelerate Gemini Enterprise Adoption at Scale7.10.2026 11:30:00 EEST | Press release
LTM, a Business Creativity partner to the world’s largest enterprises, today announced an expanded collaboration with Google Cloud to help accelerate adoption of Google Cloud’s Gemini Enterprise. The collaboration will help organizations build, deploy, and scale AI-powered solutions by combining Gemini Enterprise capabilities with LTM's deep industry expertise, engineering talent, and global delivery capabilities. As part of this collaboration, LTM is making significant investments to strengthen its Gemini Enterprise capabilities through a dedicated Gemini Enterprise Center of Excellence (CoE), Specialized Talent and Delivery Capabilities and the development of Industry-Focused AI Solutions that will be showcased at the upcoming, state-of-the-art Gemini EnterpriseCustomer Experience Center. These efforts are designed to help organizations drive enterprise-wide AI adoption, operationalize intelligent workflows, and realize business value from AI at scale. The collaboration focuses on th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom